More recently, regulatory B cell populations, such as IgD–CD27+ naïve B cells, CD1d–CD5+ B cells, and CD24–CD38hi transitional B cells, are reported to be diminished in individuals with severe depression (Ahmetspahic et al., 2018). Here, CD5 is linked to depressive symptom measurement.